Usana Health Sciences Affirms FY2026 Adj EPS Guidance of $1.95-$2.29 vs $1.95 Est; Affirms FY2026 Sales Guidance of $925.000M-$1.000B vs $938.739M Est

Benzinga Newsdesk www.benzinga.com Neutral 48.1%